Composition:
Palbociclib 75mg / 100mg / 125mg
Description:
Piclib is an advanced oncology therapy designed to slow the progression of HR-positive, HER2-negative metastatic breast cancer. It contains palbociclib, a CDK4/6 inhibitor that targets proteins responsible for cell division, effectively halting the proliferation of cancer cells. Used in combination with hormonal therapies, Piclib helps extend progression-free survival and provides a targeted treatment approach with manageable side effects.
It has become a critical component in breast cancer care, especially for patients seeking a well-tolerated oral option that works at the cellular level to delay disease advancement.
Share your experience with our medical product. Write a review!
17 Nov 2025
Early Detection Saves Lives: A Parent’s Guide to Preventive Care for Childhood Asthma
When we talk about childhood asthma, it’s not an abstract worry-it’s a very real condition that affects millions of kids worldwide.
17 Nov 2025
The Role of Lifestyle Modifications in Chronic Disease Prevention
Chronic diseases-like type 2 diabetes, heart disease, hypertension, and certain cancers-are no longer just problems for “other people.”
29 Sep 2025
Gut Health and Immunity: Why a Healthy Digestive System is Your First Line of Defense
When most people think of the immune system, they imagine white blood cells, vaccines, or medicines that protect the body from infections.
29 Sep 2025
The Future of Pain Relief: From Traditional Balms to Next-Gen Transdermal Patches
Pain is one of the most common reasons people seek medical attention, whether it’s muscle pain after a long day, joint pain due to arthritis, or chronic conditions that affect daily living.
